Amado Rafael — SEC Form 4 filings

SEC reporting owner CIK 1662119. 17 Form 4 filings on record with FilingPulse; latest filed 2026-04-08.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2024-03-19 to 2026-04-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Zai Lab Ltd (ZLAB)See Remarks1513 legs · 68,157 sh · $1,594,51023
Poseida Therapeutics, Inc. (PSTX)Director25

Form 4 filings — Amado Rafael

FiledFormIssuerReported transactionsSource
2026-04-084Zai Lab Ltd (ZLAB)Sale (S): 2,739 @ $20.45EDGAR
2026-04-034Zai Lab Ltd (ZLAB)Option exercise (M): 19,523 · Option exercise (M): 5,391 · Sale (S): 9,910 @ $20.39 · Grant/award (A): 14,905 (derivative) @ $0 · Option exercise (M): 19,523 (derivative) @ $0 · Option exercise (M): 5,391 (derivative) @ $0EDGAR
2026-03-164Zai Lab Ltd (ZLAB)Option exercise (M): 5,323 · Sale (S): 2,957 @ $18.63 · Grant/award (A): 103,950 (derivative) @ $0 · Grant/award (A): 33,783 (derivative) @ $0 · Option exercise (M): 5,323 (derivative) @ $0EDGAR
2026-03-054Zai Lab Ltd (ZLAB)Sale (S): 10,000 @ $17.38EDGAR
2026-01-024Zai Lab Ltd (ZLAB)Option exercise (M): 21,000 · Sale (S): 10,787 @ $17.43 · Option exercise (M): 21,000 (derivative) @ $0EDGAR
2025-08-124Zai Lab Ltd (ZLAB)Sale (S): 3,000 @ $35EDGAR
2025-04-074Zai Lab Ltd (ZLAB)Option exercise (M): 5,391 · Sale (S): 3,029 @ $33.11 · Option exercise (M): 5,391 (derivative) @ $0EDGAR
2025-04-034Zai Lab Ltd (ZLAB)Option exercise (M): 19,523 · Sale (S): 7,541 @ $35.89 · Option exercise (M): 19,523 (derivative) @ $0EDGAR
2025-03-194Zai Lab Ltd (ZLAB)Sale (S): 3,000 @ $38.41EDGAR
2025-03-144Zai Lab Ltd (ZLAB)Grant/award (A): 65,523 (derivative) @ $0 · Grant/award (A): 21,294 (derivative) @ $0EDGAR
2025-01-084Poseida Therapeutics, Inc. (PSTX)Code (U): 58,950 · Disposition to issuer (D): 55,200 (derivative) @ $0 · Disposition to issuer (D): 27,350 (derivative) @ $0EDGAR
2025-01-024Zai Lab Ltd (ZLAB)Option exercise (M): 21,000 · Sale (S): 7,583 @ $26.28 · Option exercise (M): 21,000 (derivative) @ $0EDGAR
2024-08-144Zai Lab Ltd (ZLAB)Sale (S): 3,115 @ $16.20EDGAR
2024-06-184Poseida Therapeutics, Inc. (PSTX)Grant/award (A): 19,650 @ $0 · Grant/award (A): 27,350 (derivative) @ $0EDGAR
2024-04-054Zai Lab Ltd (ZLAB)Option exercise (M): 5,391 @ $15.90 · Sale (S): 1,952 @ $15.67 · Option exercise (M): 5,391 (derivative) @ $0EDGAR
2024-04-034Zai Lab Ltd (ZLAB)Grant/award (A): 120,141 (derivative) @ $0 · Grant/award (A): 78,092 (derivative) @ $0EDGAR
2024-03-194Zai Lab Ltd (ZLAB)Sale (S): 2,544 @ $18.86EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1662119 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →